Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000414692 | SCV000491863 | likely benign | not provided | 2017-01-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
| Invitae | RCV000796517 | SCV000936035 | uncertain significance | Tuberous sclerosis 2 | 2018-11-24 | criteria provided, single submitter | clinical testing | This sequence change results in a premature translational stop signal in the TSC2 gene (p.Leu957*). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). However, exon 26 (sometimes referred to as exon 25 in the literature) has been shown to undergo alternative splicing and results in transcripts lacking exon 26 in many adult human tissues (PMID: 26703369). Symptoms restricted to specific cell types or adverse effects on the early developmental stages cannot be excluded if there is some expression of the rare exon 26 inclusion transcripts with this variant. This variant has not been reported in the literature in individuals with TSC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 373278). This variant is not present in population databases (ExAC no frequency). |
| Genome- |
RCV000796517 | SCV002039697 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing |